Literature DB >> 19833984

Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk.

Angela Hsu1, Andrea Card, Susan Xiaoqin Lin, Sean Mota, Olveen Carrasquillo, Andrew Moran.   

Abstract

After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P<.001) among women with CVD versus 3% (from 19.8 to 16.8%; P=.68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

Entities:  

Mesh：

Year:  2009        PMID： 19833984      PMCID： PMC2775780          DOI： 10.2105/AJPH.2009.159889

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  9 in total

1.  Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.

Authors:  Sumit R Majumdar; Elizabeth A Almasi; Randall S Stafford
Journal:  JAMA       Date:  2004-10-27       Impact factor: 56.272

2.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

3.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

4.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

Authors:  Sylvia Wassertheil-Smoller; Susan L Hendrix; Marian Limacher; Gerardo Heiss; Charles Kooperberg; Alison Baird; Theodore Kotchen; J David Curb; Henry Black; Jacques E Rossouw; Aaron Aragaki; Monika Safford; Evan Stein; Somchai Laowattana; W Jerry Mysiw
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

5.  Changes in newspaper coverage about hormone therapy with the release of new medical evidence.

Authors:  Jennifer S Haas; Berta Geller; Diana L Miglioretti; Diana S M Buist; David E Nelson; Karla Kerlikowske; Patricia A Carney; Erica S Breslau; Sarah Dash; Mary K Canales; Rachel Ballard-Barbash
Journal:  J Gen Intern Med       Date:  2006-02-22       Impact factor: 5.128

6.  Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results.

Authors:  Jennifer S Haas; Celia P Kaplan; Eric P Gerstenberger; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

8.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

9.  Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use.

Authors:  Jennifer S Haas; Diana L Miglioretti; Berta Geller; Diana S M Buist; David E Nelson; Karla Kerlikowske; Patricia A Carney; Sarah Dash; Erica S Breslau; Rachel Ballard-Barbash
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128
  9 in total
  3 in total

1.  A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Kathleen A Cronin
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

Review 2.  Precision hormone therapy: identification of positive responders.

Authors:  Y J Kim; R D Brinton
Journal:  Climacteric       Date:  2021-02-22       Impact factor: 3.005

3.  Ethyl Acetate Extract of Licorice Root (Glycyrrhiza glabra) Enhances Proliferation and Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Arezou Azizsoltani; Khosro Piri; Sahar Behzad; Masoud Soleimani; Mina Nekouei; Zahra Mahmoudi; Asad Kazemi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.